Data protection Impressum

Life sciences

Biolux Technology, a Geneva-based pioneer in light-accelerated orthodontics, has raised CHF 4 million in seed funding to revolutionize orthodontic care with cutting-edge digital solutions.

Geneva’s Biolux Technology secures CHF 4 million to advance orthodontic innovation

20 November 2024

Bracco, a global leader in diagnostic imaging, has unveiled its state-of-the-art facility in Geneva, marking a significant milestone in advancing contrast-enhanced ultrasound (CEUS) technology.

Bracco boosts ultrasound imaging capabilities with new Geneva facility

19 November 2024

Lonza strengthens its bioconjugation capabilities in Visp with two major expansions, adding three new suites and creating 300 jobs to meet growing demand.

Lonza expands bioconjugation capacity in Visp and creates 300 jobs

12 November 2024

Swissmedic, Switzerland's national regulatory authority for therapeutic products, has strengthened its role in the global healthcare landscape through strategic collaborations and innovations in regulatory science. From cross-border initiatives to advances in digital transformation, Swissmedic is positioning itself as a leader in efficient, high-quality regulatory processes, providing Swiss patients with safe and timely access to cutting-edge therapies.

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics

11 November 2024

Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases. The study, conducted with leading academic and industrial partners, demonstrates the model's potential for personalized and ethical testing.

AlveoliX achieves breakthrough with Lung-on-Chip model in respiratory research

4 November 2024

Ikerian has raised USD 8 million in Series B funding to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics. Lead investor Sanoptis has entered a strategic partnership to distribute the platform across its European network.

Ikerian secures USD 8 million and a strategic partnership with Sanoptis

29 October 2024

Distalmotion has received FDA approval for its Dexter Surgical Robot, allowing it to enter the U.S. outpatient market.

Distalmotion secures FDA approval for its Dexter surgical robot

29 October 2024

ATANIS Biotech, a leader in allergy diagnostics, has raised capital to advance its novel allergy test, FAST-PASE.

ATANIS Biotech secures new funding to launch its FAST-PASE allergy diagnostic test

28 October 2024

ONWARD Medical has raised EUR 50 million through an upsized private placement, establishing a strategic partnership with Ottobock. The funds will drive ONWARD’s research and commercialization of spinal cord therapies, with plans for collaboration with Ottobock on future innovations.

ONWARD Medical raises EUR 50 million and welcomes a new strategic partner

28 October 2024

Certification Experts, a division of Kader Group, has opened a new office on Lausanne's Biopôle campus, reinforcing its presence in Switzerland to meet rising demand for compliance and regulatory consulting in the medical device and pharmaceutical sectors.

Certification Experts expands medtech services with new office at Biopôle

28 October 2024

1 2 3 4 5 6 7 8 9 … 40